Basit öğe kaydını göster

The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

dc.contributor.authorRipley, R
dc.contributor.authorRichards, S
dc.contributor.authorWilberforce, S
dc.contributor.authorChen, ZM
dc.contributor.authorvanGijn, J
dc.contributor.authorHarrison, M
dc.contributor.authorWilhelmsen, L
dc.contributor.authorWarlow, C
dc.contributor.authorAnderson, S
dc.contributor.authorBowie, A
dc.contributor.authorBoyle, J
dc.contributor.authorBrownlie, A
dc.contributor.authorCharlton, D
dc.contributor.authorCranswick, G
dc.contributor.authorDay, L
dc.contributor.authorDennis, M
dc.contributor.authorDorman, P
dc.contributor.authorFraser, H
dc.contributor.authorKaye, M
dc.contributor.authorLindley, R
dc.contributor.authorLiu, M
dc.contributor.authorMacDonald, C
dc.contributor.authorMcCrindle, I
dc.contributor.authorMiddleton, G
dc.contributor.authorPerry, D
dc.contributor.authorScoltock, V
dc.contributor.authorSmith, B
dc.contributor.authorTaylor, H
dc.contributor.authorWaddell, F
dc.contributor.authorSandercock, P
dc.contributor.authorCollins, R
dc.contributor.authorCounsell, C
dc.contributor.authorFarrell, B
dc.contributor.authorPeto, R
dc.contributor.authorSlattery, J
dc.contributor.authorWardlaw, J
dc.contributor.authorCrowther, J
dc.contributor.authorHeineman, J
dc.contributor.authorKnight, S
dc.contributor.authorRadley, A
dc.date.accessioned2021-03-03T17:20:35Z
dc.date.available2021-03-03T17:20:35Z
dc.date.issued1997
dc.identifier.citationSandercock P., Collins R., Counsell C., Farrell B., Peto R., Slattery J., Warlow C., Anderson S., Bowie A., Boyle J., et al., "The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke", LANCET, cilt.349, sa.9065, ss.1569-1581, 1997
dc.identifier.issn0140-6736
dc.identifier.othervv_1032021
dc.identifier.otherav_493bca1d-778e-4348-849a-3efd755ea836
dc.identifier.urihttp://hdl.handle.net/20.500.12627/52685
dc.identifier.urihttps://doi.org/10.1016/s0140-6736(97)04011-7
dc.description.abstractBackground Only a few small trials have compared antithrombotic therapy (antiplatelet or anticoagulant agents) versus control in acute ischaemic stroke, and none has been large enough to provide reliable evidence on safety or efficacy.
dc.language.isoeng
dc.subjectTemel Tıp Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleThe International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
dc.typeMakale
dc.relation.journalLANCET
dc.contributor.department, ,
dc.identifier.volume349
dc.identifier.issue9065
dc.identifier.startpage1569
dc.identifier.endpage1581
dc.contributor.firstauthorID90147


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster